Nevertheless, growth stocks outperformed value stocks in 2024, and investors anticipate that trend will continue as the Federal Reserve cuts interest rates. Here are 10 of CFRA analysts' top growth stocks that have reported at least 15% annual revenue growth in the past three years:

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.

These stocks are all trading near their 52-week lows, and could be attractive options to consider. They all possess promising growth opportunities in the long run. A $5,000 investment can go a long way,

Tapping into growth stocks at the right time and sticking with them for years to come can be one of the best ways to build wealth. But not all fast-growing companies end up being great long-term investments.